1. IFN-[gamma] enables cross-presentation of exogenous protein antigen in human Langerhans cells by potentiating maturation
- Author
-
Matsuo, Mitsutoshi, Nagata, Yasuhiro, Sato, Eiichi, Atanackovic, Djordje, Valmori, Danila, Chen, Yao-Tseng, Ritter, Gerd, Mellman, Ira, Old, Lloyd J., and Gnjatic, Sacha
- Subjects
Transforming growth factors -- Research ,Dendritic cells -- Research ,Science and technology - Abstract
We compared monocyte-derived dendritic cells and transforming growth factor-[beta]1-induced Langerhans-like cells (LCs) for their capacity to cross-present exogenous NY-ESO-1 protein/antibody immune complexes to an NY-ESO-l-specific CD8+ T cell clone. In contrast to dendritic cells, LCs were not able to cross-present NY-ESO-1 to the T cell clone constitutively but did so after treatment with IFN-[gamma]. Remarkably. this IFN-[gamma]-inducible characteristic was due neither to enhanced antigen uptake nor to facilitated antigen processing in LCs. Rather, IFN-[gamma] acted at least in part by potentiating the maturation of otherwise refractory LCs, enabling in turn exogenous antigen to reach the processing machinery. This model of conditional cross-presentation establishes an original level of action for IFN-[gamma] as an effective immune modulator and supports the use of IFN-[gamma] in protein vaccination strategies targeting LCs.
- Published
- 2004